Vicplas International (SGX:569) Interest Expense : S$-1.0 Mil (TTM As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vicplas International's interest expense for the six months ended in Jan. 2024 was S$ -0.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was S$-1.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vicplas International's Operating Income for the six months ended in Jan. 2024 was S$ -1.3 Mil. Vicplas International's Interest Expense for the six months ended in Jan. 2024 was S$ -0.4 Mil. Vicplas International did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vicplas International Interest Expense Historical Data

The historical data trend for Vicplas International's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Interest Expense Chart

Vicplas International Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Interest Expense

Get a 7-Day Free Trial

-0.34

-0.61

-0.53

-0.86

-1.16

Vicplas International Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
Interest Expense	Get a 7-Day Free Trial															-0.31	-0.54	-0.58	-0.58	-0.41

Vicplas International Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$-1.0 Mil.

Vicplas International (SGX:569) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vicplas International's Interest Expense for the six months ended in Jan. 2024 was S$-0.4 Mil. Its Operating Income for the six months ended in Jan. 2024 was S$-1.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jan. 2024 was S$15.5 Mil.

Vicplas International's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

Vicplas International did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Vicplas International (SGX:569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Joo Koon Circle, Singapore, SGP, 629110

Website

https://www.vicplas.com

Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines